Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial

By sjmartinez • October 21, 2024

Herrmann K, Gafita A, de Bono JS, Sartor O, Chi KN, Krause BJ, Rahbar K, Tagawa ST, Czernin J, El-Haddad G, Wong CC, Zhang Z, Wilke C, Mirante O, Morris MJ, Fizazi K. Multivariable models of outcomes with [¹⁷⁷Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial. EClinicalMedicine. 2024 Oct 4;77:102862. doi: 10.1016/j.eclinm.2024.102862. PMID: 39430616; PMCID: PMC11490806.

Tags: 177Lu-PSMA-617, Cardiology/Epi, mCRPC, nomogram, overall survival, PSA response, Publications, Radiographic progression-free survival, VISION trial

Related Posts

Allele-specific dysregulation of lipid and energy metabolism in early-stage hypertrophic cardiomyopathy

Vaniya A, Karlstaedt A, Gulkok D, Thottakara T, Liu Y, Fan S, Eades H, Vakrou S, Fukunaga R, Vernon HJ, Fiehn O, Roselle Abraham M.[...]

Arterial-Lymphatic-Like Endothelial Cells Appear in Hereditary Hemorrhagic Telangiectasia 2 and Contribute to Vascular Leakage and Arteriovenous Malformations

Yang Y, Wu X, Zhao Y, Zhang D, Zhang L, Cai X, Ji J, Jing Z, Boström KI, Yao Y. Arterial-Lymphatic-Like Endothelial Cells Appear in[...]

Twenty Years of Sustained Improvement in Quality of Care and Outcomes for Patients Hospitalized With Stroke or Transient Ischemic Attack: Data From The Get With The Guidelines-Stroke Program

Xian Y, Li S, Jiang T, Beon CD, Poudel R, Thomas K, Reeves MJ, Smith EE, Saver JL, Sheth KN, Messé SR, Schwamm LH, Fonarow[...]